Company profile
Hypervision Surgical Ltd
Hypervision Surgical
Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging.
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Capital Name Of Class Of Shares
CapitalSH08 | Transaction MzUxMzE3Mjc5MWFkaXF6a2N4 | Paper/PDF filed
Published 11 Apr 2026 22:41
Capital Allotment Shares
CapitalSH01 | Transaction MzUxMjkzNjEyNWFkaXF6a2N4
Published 27 Mar 2026 09:38
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Unaudited Abridged
Accounts AnalysedAA | Transaction MzQzNDE3MDA4MGFkaXF6a2N4
Published 02 Sep 2024 15:55
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Hyperspectral Tissue Differentiation with High-Resolution 3D Stereoscopic Vision for Minimally Invasive Surgery
1 Oct 2024 to 31 Mar 2026
Hypervision Surgical Limited (HVS), a UK based micro-SME, will deliver the _first_ high-resolution _hyperspectral imaging (HSI) 3D stereoscopic vision system_ allowing real-time intraoperative tissue characterisation for use during minimally invasive surgery (MIS). 3D HSI will create high-resolution images equipping surgeons with visual information to cle...
Hypervision Surgical
1 Jan 2021 to 31 Oct 2023
Physical illnesses of the brain, including brain cancers and blood vessel abnormalities, have a significant and devastating impact on the lives of many UK citizens. Neurosurgical procedures play a vital role in treatment for many cases. Each year in the UK, over 70,000 patients are diagnosed with a brain tumour, of which 5,000 undergo surgery. A further 1...